Sloan Kettering Secures Sanctions In Drug IP Case
A New York magistrate judge sanctioned a biopharmaceutical company and its counsel Monday for using protected information from its now-dismissed lawsuit against the Sloan Kettering Institute for Cancer Research over gene...To view the full article, register now.
Already a subscriber? Click here to view full article